DT
TVTX icon

Diversified Trust’s Travere Therapeutics TVTX Stock Holding History

Diversified Trust’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Buy
35,281
+7,120
+25% +$316K 0.03% 270
2026
Q1 		$837K Buy
28,161
+3,117
+12% +$93.2K 0.02% 516
2025
Q4 		$957K Buy
25,044
+1,349
+6% +$43.9K 0.02% 453
2025
Q3 		$566K Buy
23,695
+796
+3% +$15K 0.01% 600
2025
Q2 		$339K Buy
22,899
+6,940
+43% +$115K 0.01% 719
2025
Q1 		$286K Buy
15,959
+1,258
+9% +$25.5K 0.01% 748
2024
Q4 		$256K Buy
14,701
+3,169
+27% +$56.1K 0.01% 785
2024
Q3 		$161K Buy
+11,532
New +$120K ﹤0.01% 846
2023
Q3 		– Sell
-14,335
Closed -$220K – 928
2023
Q2 		$220K Buy
+14,335
New +$261K 0.01% 735

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diversified Trust's TVTX Position: Q2 2026 in Review

Diversified Trust increased its Travere Therapeutics (TVTX) stake by 25% in Q2 2026, buying an estimated $316K and bringing the position to 35,281 shares worth $2M. The position accounts for 0.03% of the portfolio, ranked #270.

Diversified Trust first reported a position in TVTX in Q2 2023 and has held it in 9 quarters since. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Diversified Trust held 35,281 shares of Travere Therapeutics worth $2M as of Q2 2026.
  • Diversified Trust bought 7,120 Travere Therapeutics shares in Q2 2026, an estimated $316K.
  • Travere Therapeutics made up 0.03% of Diversified Trust's portfolio in Q2 2026, its #270 holding.
  • Diversified Trust first reported a position in Travere Therapeutics in Q2 2023 and has held it in 9 quarters since.
  • 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.